Prevalence of Hepatic Cysts
Hepatic cysts are common, occurring in approximately 15-18% of the general population based on modern imaging studies, with prevalence increasing significantly with age and showing a female predominance. 1
Epidemiology and Key Characteristics
The prevalence of simple hepatic cysts varies depending on the detection method and population studied:
- Modern ultrasound studies: 11.3% prevalence in hospital-based populations 2
- Spiral CT imaging: 18% prevalence across all ages 3
- Older ultrasound studies: 2.5% prevalence 4
- Autopsy studies: 0.2-0.5% for solitary cysts 5
The discrepancy between older and newer studies reflects improved imaging technology—spiral CT and modern ultrasound detect cysts that older equipment missed 3.
Age and Sex Distribution
Age is the most important factor affecting prevalence:
- Under 40 years: Hepatic cysts are essentially absent 2
- Over 40 years: Prevalence increases progressively with each decade 2, 3
- Female predominance: Women have higher rates (12.5%) compared to men (9.7%) 2
The right lobe of the liver is preferentially affected, and cysts can be solitary or multiple 4.
Clinical Significance
The vast majority of hepatic cysts are simple, benign lesions that remain asymptomatic throughout life and require no follow-up or treatment 6. According to the 2022 EASL guidelines, it is strongly recommended NOT to follow asymptomatic patients with simple hepatic cysts, regardless of size 6.
When Cysts Matter
Simple hepatic cysts only become clinically relevant when:
- Symptoms develop: Abdominal pain, bloating, early satiety from mass effect
- Complications occur: Infection (rare), hemorrhage (self-limited), or rupture (extremely rare)
- Massive size: Very large cysts (>20 cm) can cause compression of adjacent structures 7, 8
If symptoms occur, ultrasound should be the first diagnostic modality used 6.
Important Clinical Pitfall
The key pitfall is over-investigating and over-treating incidental simple hepatic cysts. The 2022 EASL guidelines achieved 96% consensus that asymptomatic patients should NOT be followed because of simple hepatic cysts 6. This strong recommendation prioritizes quality of life by avoiding unnecessary anxiety, repeat imaging, radiation exposure, and healthcare costs for benign lesions that will remain clinically silent in the vast majority of patients.
Treatment is only indicated when quality of life is impaired by symptoms—not based on cyst size alone 6.